Syra Health Corp.
SYRA
$0.10
-$0.0069-6.46%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.02% | 13.62% | 42.50% | 101.15% | 47.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.02% | 13.62% | 42.50% | 101.15% | 47.45% |
| Cost of Revenue | -12.67% | 31.01% | 54.36% | 90.31% | 39.07% |
| Gross Profit | 96.53% | -21.75% | 20.52% | 173.01% | 108.48% |
| SG&A Expenses | -29.93% | -27.43% | 17.13% | 60.60% | 60.35% |
| Depreciation & Amortization | -45.60% | -41.13% | 105.65% | 41.46% | 5.93% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.07% | -8.86% | 39.38% | 90.56% | 62.84% |
| Operating Income | 67.22% | 49.13% | -25.04% | -77.35% | -86.44% |
| Income Before Tax | 67.36% | 49.32% | -17.80% | -73.18% | -84.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 67.36% | 49.32% | -17.80% | -73.18% | -84.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.36% | 49.32% | -17.80% | -73.18% | -84.13% |
| EBIT | 67.22% | 49.13% | -25.04% | -77.35% | -86.44% |
| EBITDA | 67.41% | 49.23% | -21.98% | -77.92% | -87.68% |
| EPS Basic | 81.69% | 67.16% | 29.27% | -14.89% | -23.43% |
| Normalized Basic EPS | 81.68% | 67.21% | 29.33% | -14.83% | -23.40% |
| EPS Diluted | 81.69% | 67.16% | 29.27% | -14.89% | -23.43% |
| Normalized Diluted EPS | 81.68% | 67.21% | 29.33% | -14.83% | -23.40% |
| Average Basic Shares Outstanding | 78.39% | 54.44% | 66.61% | 50.78% | 49.19% |
| Average Diluted Shares Outstanding | 78.39% | 54.44% | 66.61% | 50.78% | 49.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |